AORT vs GILD · rev $242.1M vs P/E 18, rev $7.80B
Artivion Inc (AORT) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Artivion Inc (AORT) is a medical devices company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported AORT revenue for 2026-06-30 was $242.1M. Net income was -$12.1M. AORT currently screens at market cap $1.45B.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
AORT currently screens at market cap $1.45B. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the AORT and GILD stock pages for the full models.
Not investment advice.